Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04668833 · ClinicalTrials.gov registry record · Phase 2
ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT04668833: Clinical Trial Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT04668833 is a Phase 2 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04668833, a Phase 2 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if giving autologous lymphocyte infusions to patients who are receiving chemotherapy and radiation for non-small cell lung cancer or esophageal cancer is safe and effective.
Interventions
- PROCEDURE Autologous lymphocyte infusion (ALI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2020-09-29 |
| Est. Completion | 2025-10-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04668833
The ClinicalTrials.gov registry entry for NCT04668833 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Autologous lymphocyte infusion (ALI) is the first listed.
NCT04668833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04668833 about?
NCT04668833 is a clinical study titled "ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter". The goal of this clinical research study is to learn if giving autologous lymphocyte infusions to patients who are receiving chemotherapy and radiation for non-small cell lung cancer or esophageal cancer is safe and effective.
What is the current status of trial NCT04668833?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2020-09-29. Estimated completion is 2025-10-24.
What interventions are being tested in trial NCT04668833?
The interventions under investigation include: Autologous lymphocyte infusion (ALI) (PROCEDURE).
Who is sponsoring clinical trial NCT04668833?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.